ctrl K

OnKure Therapeutics Inc. (OKUR)

NASDAQ: OKUR · Real-Time Price · USD

2.50

0.01 (0.40%)

At close: May 01, 2025, 3:59 PM

2.62

4.80%

Pre-market: May 02, 2025, 04:36 AM EDT

OnKure Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-62.63M	-7.72M	-23.95M	-18.24M	-17.16M	-38.27M	-17.39M	-8.75M
Interest Income	525K	525K	525K	746K	524K	524K	524K	73K
Pretax Income	-62.56M	-8.84M	-24.35M	-18.39M	-17.54M	-36.06M	-16.86M	-8.68M
Net Income	-62.56M	-8.84M	-24.35M	-18.39M	-17.54M	-36.06M	-16.86M	-8.68M
Selling & General & Admin	5.05M	-5.6M	-2.1M	-4.57M	-4.6M	9.62M	2.35M	1.23M
Research & Development	57.58M	13.33M	26.05M	22.81M	21.77M	28.66M	15.04M	7.52M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	62.63M	7.72M	23.95M	18.24M	17.16M	38.27M	17.39M	8.75M
Interest Expense	26K	26K	26K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	62.63M	7.72M	23.95M	18.24M	17.16M	38.27M	17.39M	8.75M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M
Shares Outstanding (Diluted)	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M	13.34M
EPS (Basic)	-2.05	-2.05	-3.21	-2.76	-2.7	-2.7	-1.26	-0.65
EPS (Diluted)	-2.05	-2.05	-3.21	-2.76	-2.7	-2.7	-1.26	-0.65
EBITDA	-59.47M	-6.76M	-22.99M	-17.05M	-15.99M	-37.54M	-16.65M	-8.62M
EBIT	-60.39M	-7.5M	-23.72M	-17.79M	-16.71M	-37.82M	-16.93M	-8.75M
Depreciation & Amortization	662K	474K	576K	583K	560K	126K	283K	128K